logo
  

ANI Pharma Q1 Profit Tops Estimates

ANI Pharmaceuticals, Inc. (ANIP) reported first quarter adjusted non-GAAP earnings per share of $1.04, flat with prior year. On average, three analysts polled by Thomson Reuters expected the company to report profit per share of $0.71, for the quarter. Analysts' estimates typically exclude special items. GAAP net income was $0.1 million, and GAAP earnings per share was $0.01, for the quarter.

First quarter net revenues were $54.5 million compared to $49.8 million, last year. Analysts expected revenue of $46.8 million, for the quarter.

Cash and cash equivalents were $25.1 million, net accounts receivable was $91.9 million, as of March 31, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration said it now intends to review only a small subset of new emergency use authorization or EUA requests for diagnostic tests. As per an updated COVID-19 test policy with a view to ensure continued access to tests, the regulator further urged developers of all test types seeking marketing authorization to pursue traditional premarket review for most test types. Netflix, Inc. said it is adding a new feature to offer a more personalized mobile games experience on the platform. In a statement, Sophia Yang, Product Manager, Mobile Games, said the company is rolling out the ability to create game handles, with which members will be able to create a unique public username. This can be used across all Netflix games. General Motors Co. has delayed its plan to require employees to return to office many days a week until next year, reports said citing an internal memo signed by CEO Mary Barra. Last week, the company had announced that corporate workers would be required to return to respective offices at least three days a week, beginning later this year, as the COVID-19 pandemic eases.
Follow RTT